ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $260,560 (100.0% shares, 0.0% debt)

Holdings (9)

BEAM BEAM THERAPEUTICS INC. 45.5%

Value ($000) $118,449 Shares 4,834,653 Est. Cost $24.56 Unrealized +5.2%

RAPP RAPPORT THERAPEUTICS, INC. 29.3%

Value ($000) $76,365 Shares 3,728,738 Est. Cost $23.15 Unrealized -7.2%

ERAS ERASCA, INC. 11.6%

Value ($000) $30,182 Shares 11,055,554 Est. Cost $17.12 Unrealized -83.5%

QTTB Q32 BIO INC. 5.5%

Value ($000) $14,300 Shares 320,482 Est. Cost $13.78 Unrealized +166.7%

— VERVE THERAPEUTICS, INC. 3.7%

Value ($000) $9,723 Shares 2,008,809 Est. Cost $36.87 Unrealized —

GOSS GOSSAMER BIO, INC. 3.0%

Value ($000) $7,946 Shares 8,055,916 Est. Cost $1.15 Unrealized -16.5%

— SINGULAR GENOMICS SYSTEMS, INC. 0.8%

Value ($000) $1,984 Shares 126,630 Est. Cost $8.45 Unrealized —

— UNITY BIOTECHNOLOGY, INC. 0.6%

Value ($000) $1,477 Shares 1,004,817 Est. Cost $0.40 Unrealized —

— CERO THERAPEUTICS HOLDINGS, INC. 0.1%

Value ($000) $135 Shares 1,444,296 Est. Cost $3.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BEAM	BEAM THERAPEUTICS INC.	4,834,653	$118,449	45.5%	$24.56	+5.2%	COM	07373V105
RAPP	RAPPORT THERAPEUTICS, INC.	3,728,738	$76,365	29.3%	$23.15	-7.2%	COM	75383L102
ERAS	ERASCA, INC.	11,055,554	$30,182	11.6%	$17.12	-83.5%	COM	29479A108
QTTB	Q32 BIO INC.	320,482	$14,300	5.5%	$13.78	+166.7%	COM	746964105
—	VERVE THERAPEUTICS, INC.	2,008,809	$9,723	3.7%	$36.87	—	COM	92539P101
GOSS	GOSSAMER BIO, INC.	8,055,916	$7,946	3.0%	$1.15	-16.5%	COM	38341P102
—	SINGULAR GENOMICS SYSTEMS, INC.	126,630	$1,984	0.8%	$8.45	—	COM NEW	82933R308
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$1,477	0.6%	$0.40	—	COM NEW	91381U200
—	CERO THERAPEUTICS HOLDINGS, INC.	1,444,296	$135	0.1%	$3.07	—	CLASS A COM	71902K105